Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

BetterLife Pharma secures Mitacs Accelerate funding to research its chronic anxiety and depression candidate

% of readers think this story is Fact. Add your two cents.


BetterLife Pharma Inc (CSE:BETR, OTCQB:BETRF)’s bid to advance its TD-010 candidate to treat chronic anxiety and depression has been boosted by a funding award.

The biotech revealed it had been granted Mitacs Accelerate program funding for its joint application with Dr Argel Aguilar-Valles at Carleton University department of neuroscience to carry out research of the drug in preclinical models.

READ: BetterLife Pharma says early positive in vitro results show AP-003 has similar potent efficacy against coronavirus variants

Dr Argel Aguilar-Valles’s team, who are experts on the molecular mechanisms that underlie psychiatric and neurodevelopmental disorders, will work with BetterLife to test TD-010 in both in vitro and in vivo models that are established in the former’s lab. 

“TD-010 is a potential novel therapy to treat debilitating anxiety disorders that show resistance to benzodiazepine and other therapies or require a long-term use and therefore put patients at risk for dependency,” said Betterlife CEO Dr Ahmad Doroudian in a statement.

“BetterLife’s goal is to bring this treatment to the Investigational New Drug (IND) application and the clinic as soon as possible because it is non-addictive yet potentially highly effective.”

Dr Argel Aguilar-Valles added: “We are delighted to have the opportunity to examine TD-010 in our established animal anxiety models. The high rate of resistance to benzodiazepine and SSRIs for chronic anxiety disorder indicates an urgent unmet need for alternative anxiolytic treatments.

“TD-010 has shown to have more potent anxiolytic effects than its parent compound honokiol and it can be a promising alternative in the treatment of chronic anxiety.”

TD-010 or dihydrohonokiol-B (DHH-B) is a compound that BetterLife is developing primarily for benzodiazepine dependency in addition to anxiety. 

Each year, up to 20% of adults are affected by anxiety disorders and among the most used anxiolytic therapeutics are benzodiazepines, which from mid-February to mid-March, 2020 saw a 34% increase in prescriptions.

But Benzodiazepines have drawbacks, including a high rate of treatment resistance, dependence and serious side effects.

Contact the writer at [email protected]

Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/955747/betterlife-pharma-secures-mitacs-accelerate-funding-to-research-its-chronic-anxiety-and-depression-candidate-955747.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!


Order by Phone at 888-809-8385 or online at https://mitocopper.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomic.com M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at https://www.herbanomics.com M - F 9am to 5pm EST


Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse
Loading...

    Comments

    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    MOST RECENT
    Load more ...

    SignUp

    Login

    Newsletter

    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.